Frontier Scientific Inc. Acquires Echelon Biosciences Inc.美股频道金融界

SALTLAKECITY,Dec.3/PRNewswire/--FrontierScientificInc.,aLogan,Utah,baseddiscoverybiochemistrycompanyprovidingreagentsandfinechemicalsforresearchanddrugdiscoveryhasacquiredEchelonBiosciencesInc.,aSaltLakeCitybasedbiotechnologycompany,fromAeternaZentarisInc.(Nasdaq:AEZS-News).

(Logo:http://www.newscom.com/cgi-bin/prnh/20071203/LAM058LOGO

http://www.newscom.com/cgi-bin/prnh/20070613/ECHELONLOGO)

Bothcompanieswillbenefitfromthisnewrelationship.Frontierhasaproventrack-recordofspecializedbiochemicalsyntheticorganicchemistrywithexperienceindrugdevelopment,smallmoleculebuildingblocks,andmaterialscience.Itsuniquelight-activatedchemistrieshavebroadindustrialandmedicalapplications.OneofFrontier"smoleculesisapprovedforcertaincancertumortreatmentinJapanandisinlatestagehumanstudiesintheUS.Echelonhasasuccessfulhistoryandisaworld-recognizedexpertinthedevelopmentandmarketingofcriticalreagentsandassaystolookinsidethehumancellatlipids-relatedsignalingmistakesthatleadtodiseaseslikecancer,diabetes,andinflammation.Itpreviouslyhasmovedsmallmoleculesintosuccessfulearlyanimalstudiestargetingovariancancer.Bothcompanieshavepromisingactivitiesinthefieldofnewpotentialantibacterials.

Dr.JerryBommer,PresidentofFrontierScientificcommented,"FrontierScientificandEchelonBiosciencesbothhaveoutstandingpersonnelandcomplementarymarkets,technologies,facilities,andoperations.Theacquisitionwillleadtonewtechnologydevelopmentandgrowthopportunities.Weareexcitedtoblendourscientificteamsandexpandbothcompanies"activitiesincellbiology,diseasedetection,andpotentialnewdrugdevelopment."

W.TimMiller,PresidentandCEOofEchelonBiosciencesstated,"Weareexcitedaboutthecombinationonanumberoffrontsincludingexcitingscientificsynergybetweenthetwocompanies,blendingtwooutstandingteamsofemployees,astrengthenedbiotechnologybasefortheStateofUtah,andtheopportunitytomergetwocriticallyimportantbiologicalplatformsforimproveddiagnosticsandtherapeutics.Ourcommonhumanbiologyfocusanduniquebutcomplementaryscientificskillsetswillallowustoleveragesignificantlyeachothers"efforts."

Thecompaniesaddressacommonlifesciencesresearchcustomerbasewhichincludesmajorpharmaceuticalcompaniesandresearchuniversitiesaroundtheworld.ThecompanieswillmaintaintheircurrentfacilitiesinLoganandSaltLakeCityandbegintoworktowardacommonseniormanagementstructure.

AboutFrontierScientific,Inc.

FrontierScientificInc.(FSI)isachemicaldeveloper,manufacturerandcustomresearchservicesprovidertothepharmaceutical,biotechnology,industrialchemical,government,andacademicsectors.FSIspecializesinthedevelopmentofchemicalcompoundsandprocessesrelatedtoporphyrins,phthalocyaninesandboronicacids.FSIisaprivatelyheldcorporationestablishedin1975andheadquarteredinLogan,Utah.

AboutEchelonBiosciencesInc.

EchelonBiosciencesInc.isengagedinfurtheringthescienceoflipidcellsignallingandcriticalmetabolicenzymes,whichprovidenewandviabletargetsforthedevelopmentofpotentialdrugsanddiagnosticsforcancer,diabetes,inflammation,infections,andcardiovasculardisease.Echelon"snovelassaysareusedbyscientistsaroundtheworldtoidentifyenzymeinhibitorsandsignalingantagonistsinthesearchforanewgenerationofpharmaceuticals.Echelonisaninnovativerapidlygrowingcompanythatiscommittedtoacceleratingdrugdiscoveryandbringinglifesavingtherapeuticstomarket.

Source:EchelonBiosciencesInc.